Anteris as a surgical solution will look a lot more viable to health admins when it has the backing of a multi-billion, multi-national company.
Nobody wants to sue a 300, 400, 6,7,800 $mill company, you'll only get peanuts out them.
- Forums
- ASX - By Stock
- Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
Anteris as a surgical solution will look a lot more viable to...
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.65 |
Change
-0.650(3.55%) |
Mkt cap ! $346.4M |
Open | High | Low | Value | Volume |
$18.29 | $18.30 | $17.65 | $105.7K | 5.908K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 401 | $17.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.01 | 29 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 401 | 17.700 |
2 | 296 | 17.650 |
2 | 700 | 17.550 |
1 | 1 | 17.510 |
3 | 1850 | 17.500 |
Price($) | Vol. | No. |
---|---|---|
18.010 | 29 | 2 |
18.030 | 25 | 1 |
18.040 | 430 | 1 |
18.050 | 50 | 1 |
18.070 | 26 | 1 |
Last trade - 13.35pm 05/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |